1. Home
  2. FRSX vs VCEL Comparison

FRSX vs VCEL Comparison

Compare FRSX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.89

Market Cap

4.9M

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$46.43

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSX
VCEL
Founded
N/A
1989
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
1.7B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
FRSX
VCEL
Price
$1.89
$46.43
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.75
AVG Volume (30 Days)
1.6M
710.2K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
N/A
Revenue
N/A
$276,259,000.00
Revenue This Year
N/A
$19.40
Revenue Next Year
N/A
$18.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.45
52 Week Low
$0.31
$28.95
52 Week High
$3.00
$47.06

Technical Indicators

Market Signals
Indicator
FRSX
VCEL
Relative Strength Index (RSI) 52.65 77.16
Support Level $1.24 $32.47
Resistance Level $1.90 N/A
Average True Range (ATR) 0.16 1.72
MACD 0.04 0.63
Stochastic Oscillator 70.00 99.19

Price Performance

Historical Comparison
FRSX
VCEL

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: